Processa shareholders elect all six directors and approve warrant share issuance at 2025 annual meeting

Processa Pharmaceuticals, Inc.

All six director nominees elected: Justin Yorke, George Ng, Khoso Baluch, James Neal, Geraldine Pannu, Dr. David Young.
Proposal to issue shares upon exercise of Series A and B warrants approved with 1,646,114 for, 275,707 against, 24,613 abstain.
Ratification of Cherry Bekaert, LLP as independent auditor for FY2025 passed with 3,752,298 for, 166,735 against.
Advisory vote on executive compensation approved: 1,704,544 for, 224,727 against, 17,163 abstain.
Meeting held July 18, 2025; broker non-votes on director and other proposals totaled 2,035,053 shares.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.